口腔颌面-头颈部癌肉瘤10例临床分析

doi:10.19439/j.sjos.2017.05.022

上海口腔医学 ›› 2017, Vol. 26 ›› Issue (5): 569-572.doi: 10.19439/j.sjos.2017.05.022

• 论著 • 上一篇

口腔颌面-头颈部癌肉瘤10例临床分析

何海蕾¹, 刘忠龙², 马春跃², 李晓光², 何悦²

1.南昌大学附属赣州医院暨赣州市人民医院口腔颌面外科,江西赣州 341000；
2.上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤科,上海 200011;

收稿日期:2017-01-12 修回日期:2017-05-16 出版日期:2017-10-25 发布日期:2017-11-23
通讯作者: 何悦,E-mail:yuehe@sjtu.edu.cn
作者简介:何海蕾（1980-）,男,硕士,主治医师,E-mail:hehailei006@163.com

Clinicopathological features of carcinosarcoma in oromaxillofacial head and neck region

HE Hai-lei¹, LIU Zhong-long², MA Chun-yue², LI Xiao-guang², HE Yue²

1.Department of Stomatology. Ganzhou People's Hospital. Ganzhou 341000, Jiangxi Province;
2.Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine. Shanghai 200011, China

Received:2017-01-12 Revised:2017-05-16 Online:2017-10-25 Published:2017-11-23

摘要/Abstract

摘要： 目的探讨口腔颌面-头颈部癌肉瘤（carcinosarcoma）的临床特征、病理特征、治疗方法及预后。方法对上海交通大学医学院附属第九人民医院收集的10例口腔颌面-头颈部癌肉瘤患者的临床及病理资料进行分析,包括临床表现、影像学表现、病理表现、治疗及愈后等方面。结果10例患者中,男8例,女2例;年龄20~81岁,平均44岁（中位年龄45.5岁）。肿瘤大小不一,直径在1.5 cm以上,与发生部位有关。临床表现多为异物感或迅速增大的肿物,甚至疼痛不适。病理证实含癌及肉瘤样间质,为癌肉瘤。临床上主要与鳞癌相鉴别,确诊取决于术后病理检查尤其是免疫组织化学分析。鳞状细胞癌为上皮样组织的恶性肿瘤,而癌肉瘤则兼有上皮样组织及间叶样组织。预后较差,5年生存率50%。结论癌肉瘤确诊依赖于术后病理学检查,手术完整切除+血管化皮瓣修复+术后放疗为常规治疗方法,根据实际情况予以化疗。

关键词: 口腔颌面-头颈部, 癌肉瘤, 临床病理特征

Abstract: PURPOSE: To analyze the clinical features, histopathological features, treatment and prognosis of carcinosarcoma in oromaxillofacial head and neck region. METHODS: The clinical and histopathological data of 10 cases with carcinosarama were collected from database of Shanghai Ninth People's Hospital and further analyzed. RESULTS: A total of 10 cases (8 males and 2 females) of carcinosarcoma were collected and analyzed. The age of patients ranged from 20 to 81 years (mean: 44, median:45.5). The tumor size was related to the primary site. The main clinical manifestations indicated rapid increase of foreign body sensation or mass, even feeling of pain. Pathologic examination confirmed the presence of carcinoma and sarcomatoid stroma. Carcinosarcoma had low incidence and was easily misdiagnosed. Diagnosis depended on pathologic examination especially immunohistochemistry. The prognosis was poor, and 5 year survival rate was 50%. CONCLUSIONS: Diagnosis to carcinosarcoma depends on pathological examination after operation. Complete resection + free flap transplantation + postoperative radiotherapy and chemotherapy are conventional treatment.

Key words: Oromaxillofacial head and neck region, Carcinosarcoma, Clinicopathological features

中图分类号:

R739.8

何海蕾, 刘忠龙, 马春跃, 李晓光, 何悦. 口腔颌面-头颈部癌肉瘤10例临床分析[J]. 上海口腔医学, 2017, 26(5): 569-572.

HE Hai-lei, LIU Zhong-long, MA Chun-yue, LI Xiao-guang, HE Yue. Clinicopathological features of carcinosarcoma in oromaxillofacial head and neck region[J]. Shanghai Journal of Stomatology, 2017, 26(5): 569-572.

参考文献

[1] 方铣华, 林雪平. 肉瘤样癌及癌肉瘤的新认识 [J].肿瘤研究与临床, 2005, 17(2): 138-139.
[2] Pelosi, G, SonzogniA, De Pas T, et al. Review article: pulmonary sarcomatoid carcinomas: a practical overview[J]. Int J Surg Pathol, 2010, 18(2): 103-120.
[3] Thompson LD, Wieneke JA, Miettinen M, et al. Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases [J]. Am J Surg Pathol, 2002, 26(2): 153-170.
[4] 张海萍, 张海芳, 陈培琼. 腮腺癌肉瘤1例[J]. 中华病理学杂志, 2011, 40(10): 703-7044.
[5] Keh SM, Tait A, Ahsan SF. Priman careinosarcoma of the parotid gland [J]. Clin Pract, 2011, l(4): e117.
[6] Taki NH, Laver N, Quinto T, et al. Carcinosarcoma de novo of the parotid gland: case report[J]. Head Neck, 2013, 35(5): E161-163.
[7] 王兆元, 张英, 王洁. 牙源性癌肉瘤1例报告 [J]. 中国医科大学学报, 2006, 35(5): 509.
[8] Tanaka N, HidakaS, Yamamura M, Metastatic cutaneous carcinosarcoma to the tongue [J]. Int J Oral Maxillofac Surg, 2010, 39(10): 1033-1036.
[9] Suzuki H, YamashiroK, Yoshida C, et al. Carcinosarcoma of the tongue with cyclin D1 gene amplification [J]. Arch Pathol Lab Med, 2001, 125(3): 433-436.
[10] Takata T, Nikai H, Ogawa I, et al. Ultrastructural and immunohistochemical observations of a true malignant mixed tumor (carcinosarcoma) of the tongue [J]. J Oral Pathol Med, 1990, 19(6): 261-265.
[11] Slama A, Yacoubi T, Khochtali H, et al. Mandibular odontogeniccarcinosarcoma: a case report [J]. Rev Stomatol Chir Maxillofac, 2002, 103(2): 124-127.
[12] Stojadinovic S, Reinet S, Philippou ST, et al. Carcinosarcoma of the mandibular mucosa: the first report [J]. Int J Oral Maxillofac Surg, 2002, 31(4): 444-447.
[13] Shen XZ, Liu F. Primary sarcomatoid carcinoma of the mandibular gingiva: clinicopathological and radiological findings [J]. Singapore Med J, 2014, 55(9): e152-155.
[14] Wick MR, Ritter JH, Humphrey PA. Sarcomatoid carcinomas of the lung: a clinicopathologic review [J]. Am J Clin Pathol, 1997, 108(1): 40-53.
[15] Wright JL, Black PC, Brown GA, et al. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder [J]. J Urol, 2007, 178(6): 2302-2306.
[16] Cornette J, Tjalma WA, Buytaert P. Biphasic sarcomatoid carcinoma or carcinosarcoma of the breast: prognosis and therapy [J]. Eur J Gynaecol Oncol, 2005, 26(5): 514-516.
[17] 方铣华, 倪型灏. 喉部肉瘤样癌11例临床病理分析[J]. 中国肿瘤, 2002, 11(9): 547-548.

口腔颌面-头颈部癌肉瘤10例临床分析

Clinicopathological features of carcinosarcoma in oromaxillofacial head and neck region

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	赵娇, 隋佰延, 刘昕, 阮敏. 口腔鳞状细胞癌免疫相关预后风险模型的构建与验证[J]. 上海口腔医学, 2024, 33(4): 345-353.
[2]	李欣然, 陈霖, 孟箭. 斑蝥酸钠对人舌鳞癌CAL27细胞的抑制作用及机制研究[J]. 上海口腔医学, 2024, 33(3): 229-234.
[3]	刘丽敏, 孙晶晶, 钱佳骏, 张春叶, 胡宇华, 李江. 171例颌面部骨软骨瘤及恶变病例临床病理分析[J]. 上海口腔医学, 2024, 33(3): 324-327.
[4]	周辉红, 陈倩倩, 袁方, 孙晶晶, 田臻, 熊屏. 7例头颈部Castleman病超声特征分析[J]. 上海口腔医学, 2024, 33(3): 328-331.
[5]	谢玉婷, 熊屏. 基于单原子铁纳米催化剂的纳米催化疗法对口腔鳞癌细胞Cal27的作用[J]. 上海口腔医学, 2024, 33(2): 117-122.
[6]	赵开, 张宇宁, 纪帅旗, 刘颖, 姜涵. CFL-1在头颈部鳞癌中的表达与患者预后的关系[J]. 上海口腔医学, 2024, 33(2): 148-155.
[7]	李晓娜, 宗颖睿, 张彦喜, 候珍珍, 卢丽雯. 全身免疫炎症指数列线图对黏液表皮样癌预后预测价值的研究[J]. 上海口腔医学, 2024, 33(2): 205-210.
[8]	陈倩倩, 余强, 孙晶晶, 熊屏. 12例Warthin瘤样黏液表皮样癌影像学分析[J]. 上海口腔医学, 2024, 33(2): 219-224.
[9]	郝妍, 白相宇, 霍峰, 陈喜波. 下调SETDB1通过SOX7甲基化抑制口腔癌上皮-间充质转化、侵袭和转移的机制探讨[J]. 上海口腔医学, 2024, 33(1): 30-35.
[10]	刘文静, 李梦琦, 崔祥, 汪俊兰. circ_0000326靶向miR-567对口腔鳞状细胞癌HSC3细胞增殖、侵袭及迁移的调控效应[J]. 上海口腔医学, 2023, 32(6): 590-596.
[11]	刘芸, 陈浩月, 米静, 王菲菲, 万光勇, 崔超. 芍药苷对舌鳞癌CAL27细胞的抑制作用及机制探讨[J]. 上海口腔医学, 2023, 32(6): 597-602.
[12]	陈兴金, 范然怡, 陶识丞, 薛睿, 文旭涛, 麦华明. 颈淋巴清扫术保留胸锁乳突肌与否对晚期口腔鳞癌预后的影响[J]. 上海口腔医学, 2023, 32(6): 609-614.
[13]	裴婧, 张林, 贾云香, 陈蔚华. BRAF V600E在成釉细胞瘤、成釉细胞癌和囊肿中的表达[J]. 上海口腔医学, 2023, 32(6): 630-634.
[14]	叶婷婷, 陈蔚华, 裴婧, 贾云香, 吴海莹. NEK2与EMT相关分子在口腔鳞状细胞癌中的表达及临床意义[J]. 上海口腔医学, 2023, 32(6): 640-644.
[15]	李胜男, 崔飞艳, 赵姗, 杜琛, 孟箭. 柯里拉京体内外诱导口腔鳞癌CAL-27细胞凋亡及机制探讨[J]. 上海口腔医学, 2023, 32(5): 462-467.